3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Plasma cell
1
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Interventions
Carboplatin
88
pembrolizumab
77
Pemetrexed
65
Cisplatin
56
Paclitaxel
33
Docetaxel
31
durvalumab
28
atezolizumab
28
Nivolumab
28
Specimen Handling
25
Magnetic Resonance Spectroscopy
20
Gemcitabine
19
osimertinib
18
130-nm albumin-bound paclitaxel
18
Etoposide
17
Radiotherapy
14
Cetuximab
14
Platinum
12
Taxes
11
Immunoglobulin G
10
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Ipilimumab
9
Disulfides
9
Bevacizumab
9
amivantamab
8
Topotecan
8
fludarabine
7
Ramucirumab
7
Radiosurgery
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
cobimetinib
×
Thoracic
×
30 days
×
Clear all
NCT03178552
2026-06-05
B-FAST
Hoffmann-La Roche
Phase 2/3
Active not recruiting
1,000 enrolled
NCT04302025
2026-05-22
NAUTIKA1
Genentech, Inc.
Phase 2
Recruiting
99 enrolled